Atara Biotherapeutics Inc Stock price
Is Atara Biotherapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.
Key metrics
Atara Biotherapeutics Inc Stock Analysis
Analyst Opinions
10 Analysts have issued a Atara Biotherapeutics Inc forecast:
Analyst Opinions
10 Analysts have issued a Atara Biotherapeutics Inc forecast:
Atara Biotherapeutics Inc Events
Upcoming Event
Don't miss a Thing! We will send you all news about Atara Biotherapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Atara Biotherapeutics Inc Stock News
Company Profile
Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.
| Head office | United States |
| CEO | Mr. Nguyen |
| Employees | 14 |
| Founded | 2012 |
| Website | www.atarabio.com |


